Medcorp (TRN:MED) Research & Development: TTD Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TRN:MED Medcorp Ltd TRN:MED
42 GF Score
Price TTD43.75
! 1 Warning Sign
View Full Analysis

What is Medcorp Research & Development?

Medcorp TRN:MED 42 Research & Development is TTD Mil as of . 20. GuruFocus rates TRN:MED with a GF Score™ of 42/100. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Medcorp's Research & Development for the six months ended in . 20 was TTD0.00 Mil. Medcorp does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

Medcorp  (TRN:MED) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Medcorp Research & Development Related Terms

Medcorp Research & Development Historical Data

* Premium members only.

The historical data trend for Medcorp's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medcorp Research & Development Chart

Medcorp Annual Data
Trend
Research & Development

Medcorp Semi-Annual Data
Research & Development
TRN:MED
42GF Score
Medcorp Ltd TRN:MED
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medcorp Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of TTD Mil mean?
Medcorp (TRN:MED) has a Research & Development of TTD Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on Medcorp and its competitors.
Is Medcorp's Research & Development too high?
Medcorp's current Research & Development is TTD Mil. Overall, Medcorp has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Medcorp's Research & Development compare to HCA and THC?
Medcorp's Research & Development of TTD Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Medcorp and its competitors. Medcorp's current Research & Development is TTD Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medcorp stock overvalued right now?
Medcorp (TRN:MED) has a current Research & Development of TTD Mil. The current Research & Development is TTD Mil. Medcorp's overall GF Score™ is 42/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Medcorp (TRN:MED), the current Research & Development is TTD Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medcorp Business Description

Address 18 Elizabeth Street, Saint Clair, Port-of-Spain, TTO
Medcorp Ltd operates as a private healthcare facility in the Republic of Trinidad and Tobago. The company's main business is the operation of a private hospital, the provision of radiology services, and the provision of cancer treatment services. Its services include 24-Hour Accident & Emergency, Diagnostic Services, Dialysis Service, Executive Health Assessment, Intensive Care Unit, Maternity & Nursery Services, Nursing Care Services, Pharmacy Services, Support Services, and Surgical Services.
42GF Score

Get the complete analysis for TRN:MED

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

TTD43.75
Price